Physical symptoms from prostate biopsy can cause anxiety

October 23, 2013
Physical symptoms from prostate biopsy can cause anxiety

(HealthDay)—Problematic symptoms of prostate biopsy can lead to increased anxiety in men, even when the biopsy results are negative for cancer, according to research published online Oct. 21 in the Journal of Clinical Oncology.

Julia Wade, Ph.D., of the University of Bristol in the United Kingdom, and colleagues analyzed data from questionnaires completed by 1,144 , among those enrolled in the Prostate Testing for Cancer and Treatment trial, to assess the psychological impact of .

The researchers found that biopsy-related symptoms were minor or not a problem, and overall levels of anxiety and depression were low, for most men. Among 471 men who received a negative biopsy result, those who had biopsy-related symptoms at seven days, including pain, shivers, hematuria, hematochezia, and hemoejaculate, that were problematic had significantly greater anxiety than those who had symptoms that were non-problematic. At 35 days, although symptoms were not reduced, anxiety was lessened.

"Problematic post-biopsy symptoms can lead to increased , distinct from distress related to diagnosis of prostate ," the authors write. "Men and doctors need to consider these additional potential harms of biopsy when deciding whether to initiate prostate-specific antigen testing."

Explore further: PCA3 assay ups predictive accuracy for repeat biopsy

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

PCA3 assay ups predictive accuracy for repeat biopsy

June 13, 2013
(HealthDay)—For men with at least one prior negative biopsy, urinary PCA3 scores, together with serum prostate-specific antigen and other clinical information, improve the prediction accuracy for repeat biopsy outcome, ...

New early detection test for prostate cancer: Mi-Prostate Score test improves on PSA for predicting cancer

September 26, 2013
More than 1 million men will undergo a prostate biopsy this year, but only about one-fifth of those biopsies will result in a cancer diagnosis.

Comorbidities should be factor in prostate biopsy choice, study finds

May 15, 2013
UC Irvine Health urologists and health policy experts report in a new study that two written assessments that identify existing comorbidities – the patient-reported Total Illness Burden Index for Prostate Cancer (TIBI-Cap) ...

Organized screening for prostate cancer does more harm than good

September 30, 2013
Prostate cancer screening using the prostate-specific antigen (PSA) test is widely used in France despite a lack of evidence showing that it reduces cancer deaths. Now, researchers have shown that men experience more harm ...

Benefits of prostate-specific antigen testing remain unclear

July 20, 2012
(HealthDay) -- It remains unclear whether the benefits of prostate-specific antigen (PSA) testing outweigh the harms, but evidence suggests that men with a longer life expectancy may benefit from testing, according to a provisional ...

Obese men at high risk for prostate cancer even after benign biopsy

April 23, 2013
Obese men were more likely to have precancerous lesions detected in their benign prostate biopsies compared with non-obese men, and were at a greater risk for subsequently developing prostate cancer, according to researchers ...

Recommended for you

New approach attacks 'undruggable' cancers from the outside in

January 23, 2018
Cancer researchers have made great strides in developing targeted therapies that treat the specific genetic mutations underlying a patient's cancer. However, many of the most common cancer-causing genes are so central to ...

Scientists block the siren call of two aggressive cancers

January 23, 2018
Aggressive cancers like glioblastoma and metastatic breast cancer have in common a siren call that beckons the bone marrow to send along whatever the tumors need to survive and thrive.

'Hijacker' drives cancer in some patients with high-risk neuroblastoma

January 23, 2018
Researchers have identified mechanisms that drive about 10 percent of high-risk neuroblastoma cases and have used a new approach to show how the cancer genome "hijacks" DNA that regulates other genes. The resulting insights ...

Enzyme inhibitor combined with chemotherapy delays glioblastoma growth

January 23, 2018
In animal experiments, a human-derived glioblastoma significantly regressed when treated with the combination of an experimental enzyme inhibitor and the standard glioblastoma chemotherapy drug, temozolomide.

Study: Cells of three advanced cancers die with drug-like compounds that reverse chemo failure

January 23, 2018
Researchers at Southern Methodist University have discovered three drug-like compounds that successfully reverse chemotherapy failure in three of the most commonly aggressive cancers—ovarian, prostate and breast.

Researchers identify a protein that keeps metastatic breast cancer cells dormant

January 23, 2018
A study headed by ICREA researcher Roger Gomis at the Institute for Research in Biomedicine (IRB Barcelona) has identified the genes involved in the latent asymptomatic state of breast cancer metastases. The work sheds light ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.